Answers are grounded in this paper and cite their sources.
), the developed PPI-MAL DS-DOTA(Gd) nanocomplexes can be used as an efficient contrast agent for MR imaging of cancer cells in vitro, and animal aorta, renal artery, kidney, and bladder in vivo. Furthermore, tissue distribution studies show that the glycodendrimer/Gd complexes are metabolized and cleared out of the body at 48 h post injection. The developed PPI-MAL DS-DOTA(Gd) may be further functionalized for MR imaging of different biological systems.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: